Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease (Go To Sleep)

This study has been completed.
Information provided by (Responsible Party):
VA Office of Research and Development
ClinicalTrials.gov Identifier:
First received: September 24, 2009
Last updated: August 10, 2015
Last verified: August 2015
Results First Received: March 31, 2015  
Study Type: Interventional
Study Design: Allocation: Randomized;   Endpoint Classification: Efficacy Study;   Intervention Model: Parallel Assignment;   Masking: Open Label;   Primary Purpose: Treatment
Conditions: Obstructive Sleep Apnea
Transient Ischemic Attack
Intervention: Procedure: CPAP Therapy for Newly Diagnosed Obstructive Sleep Apnea (OSA)

  Participant Flow
  Hide Participant Flow

Recruitment Details
Key information relevant to the recruitment process for the overall study, such as dates of the recruitment period and locations
No text entered.

Pre-Assignment Details
Significant events and approaches for the overall study following participant enrollment, but prior to group assignment
No text entered.

Reporting Groups
Intervention The intervention group received unattended polysomnography and auto-titrating CPAP if sleep apnea was diagnosed
Control The control group received usual clinical care which may include receipt of sleep diagnostic and therapeutic services

Participant Flow:   Overall Study
    Intervention     Control  
STARTED     110     115  
COMPLETED     92     109  
NOT COMPLETED     18     6  

  Baseline Characteristics
  Hide Baseline Characteristics

Population Description
Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.
No text entered.

Reporting Groups
Intervention No text entered.
Control No text entered.
Total Total of all reporting groups

Baseline Measures
    Intervention     Control     Total  
Number of Participants  
[units: participants]
  110     115     225  
[units: years]
Mean (Standard Deviation)
  69.7  (10.4)     70.2  (10.1)     70  (10)  
[units: participants]
Female     1     5     6  
Male     109     110     219  

  Outcome Measures
  Show All Outcome Measures

1.  Primary:   Sleep Apnea Diagnosis Rate   [ Time Frame: The entire study period (baseline and up to one-year) ]

2.  Primary:   Hypertension Control   [ Time Frame: One year ]

3.  Secondary:   Sleep Apnea Treatment Rate   [ Time Frame: One year ]

  Serious Adverse Events

  Other Adverse Events

  Limitations and Caveats
  Hide Limitations and Caveats

Limitations of the study, such as early termination leading to small numbers of participants analyzed and technical problems with measurement leading to unreliable or uninterpretable data
No text entered.

  More Information
  Hide More Information

Certain Agreements:  
All Principal Investigators ARE employed by the organization sponsoring the study.

Results Point of Contact:  
Name/Title: Dawn M. Bravata, MD
Organization: Department of Veterans Affairs
phone: 317-988-2676
e-mail: dawn.bravata2@va.gov

Publications of Results:
Schmid AA, Yaggi HK, Burrus N, McClain V, Austin C, Ferguson J, Fragoso C, Sico J, Ofner S, Miech EJ, Matthias MS, Williams LS, Bravata DM. The Circumstances and Consequences of Post-Stroke Falls. [Abstract]. Stroke; A Journal of Cerebral Circulation. 2013 Feb 1; 44(2):TP318.

Other Publications:
Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 1;127(1):e6-e245. doi: 10.1161/CIR.0b013e31828124ad. Epub 2012 Dec 12. Review. Erratum in: Circulation. 2013 Jun 11;127(23):e841. Circulation. 2013 Jan 1;127(1):doi:10.1161/CIR.0b013e31828124ad.

Responsible Party: VA Office of Research and Development
ClinicalTrials.gov Identifier: NCT00984308     History of Changes
Obsolete Identifiers: NCT00807417
Other Study ID Numbers: IIR 06-233
Study First Received: September 24, 2009
Results First Received: March 31, 2015
Last Updated: August 10, 2015
Health Authority: United States: Federal Government